>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

HHS Releases Omnibus HIPAA Rule

Wednesday, January 23, 2013

The Department of Health and Human Services (HHS) recently released the omnibus Health Insurance Portability and Accountability Act (HIPAA) final rule.  In a press release, HHS cited enhancing patient privacy protections and patient rights to their health information as the primary reasons for the omnibus rule. 

ASA is currently analyzing the entire 563 page rule.  Some areas of preliminary interest include:

  • Adoption of a default presumption that an impermissible use or disclosure is a data breach unless it can be determined through a risk assessment that there is a low probability that data may be compromised (under HITECH breach notification requirements).
  • Implementation of the HIPAA language related to the expansion of privacy & security obligations to business associates. 
  • Strengthens the government’s enforcement authority.
  • Requires updates to the notice of privacy practices. 

« Back to Washington Alerts